Earnings Per Share, Diluted of Aldeyra Therapeutics, Inc. from 31 Mar 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Aldeyra Therapeutics, Inc. quarterly and annual Earnings Per Share, Diluted in USD/shares history and change rate from 31 Mar 2013 to 31 Dec 2025.
  • Aldeyra Therapeutics, Inc. Earnings Per Share, Diluted for the quarter ending 31 Dec 2025 was -0.1, a 63% increase year-over-year.
  • Aldeyra Therapeutics, Inc. Earnings Per Share, Diluted for the twelve months ending 31 Dec 2025 was -0.56, a 40% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Earnings Per Share, Diluted for 2025 was -0.56, a 40% increase from 2024.
  • Aldeyra Therapeutics, Inc. annual Earnings Per Share, Diluted for 2024 was -0.94, a 47% decline from 2023.
  • Aldeyra Therapeutics, Inc. annual Earnings Per Share, Diluted for 2023 was -0.64, a 40% increase from 2022.
Source SEC data
View on sec.gov
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Change (%)
Earnings Per Share, Diluted, Annual (USD/shares)
Earnings Per Share, Diluted, YoY Annual Change (%)

Aldeyra Therapeutics, Inc. Quarterly Earnings Per Share, Diluted (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 -0.56 -0.1 +0.17 +63% 01 Oct 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 -0.73 -0.13 +0.12 +48% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 -0.85 -0.16 +0.12 +43% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 -0.97 -0.17 -0.03 -21% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 -0.94 -0.27 -0.19 -238% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 -0.75 -0.25 -0.11 -79% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 -0.64 -0.28 -0.13 -87% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 -0.51 -0.14 +0.13 +48% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 -0.64 -0.08 +0.14 +64% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 -0.78 -0.14 +0.11 +44% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 -0.89 -0.15 +0.15 +50% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 -1.04 -0.27 +0.02 +6.9% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 -1.06 -0.22 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 -0.25 +0.02 +7.4% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 -0.3 -0.02 -7.1% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 -0.29 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q3 2021 -0.27 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 -0.28 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2016 -1.59 -0.51 -0.19 -59% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 -1.4 -0.46 -3.33 -116% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
Q3 2015 1.93 -0.35 +0.01 +2.8% 01 Jul 2015 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 1.92 -0.27 +1.29 +83% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 0.63 -0.32 +3.72 +92% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 -3.09 2.87 -7.83 -73% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 4.74 -0.36 +9.45 +96% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2015 Q3
Q2 2014 -4.71 -1.56 +3.91 +71% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 -8.62 -4.04 +8.99 +69% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q4 2013 -17.61 10.7 01 Oct 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
Q3 2013 -9.81 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 -5.47 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 -13.03 01 Jan 2013 31 Mar 2013 10-Q 11 Jun 2014 2014 Q1

Aldeyra Therapeutics, Inc. Annual Earnings Per Share, Diluted (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 -0.56 +0.38 +40% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 -0.94 -0.3 -47% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 -0.64 +0.42 +40% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 -1.06 +0.01 +0.94% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 -1.07 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2015 -1.4 +1.69 +55% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
2014 -3.09 +14.52 +82% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 -17.61 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.